Matrix Metalloproteinase 2 May Be a Marker of Microangiopathy in Children and Adolescents With Type 1 Diabetes

Diabetes Care - Tập 27 Số 1 - Trang 273-274 - 2004
Giuseppe Derosa1,2, Maria Antonietta Avanzini3, Diego Geroldi1, Roberto Fogari1, Renata Lorini4, Annalisa De Silvestri5, Carmine Tinelli5, G Rondini6, Giuseppe d’Annunzio6,7
1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
2IRCCS Fondazione Policlinico San Matteo
3Research Laboratories for Pediatric Oncohematology and Immunology, IRCCS Policlinico S. Matteo, Pavia, Italy
4Department of Pediatrics, University of Genova, G. Gaslini Institute, Genova, Italy
5Biometric Unit, IRCCS Policlinico S Matteo, Pavia, Italy
6Department of Pediatrics, IRCCS Policlinico S. Matteo, Pavia, Italy
7Istituto “Giannina Gaslini”

Tóm tắt

Từ khóa


Tài liệu tham khảo

Law GR, McKinney PA, Staines A, Williams R, Kelly M, Alexander F, Gilman E, Bodansky HJ: Clustering of childhood IDDM: links with age and place of residence. Diabetes Care 20:753–756, 1997

Pomilio MP, Mohn A, Verrotti A, Chiarelli F: Endothelial dysfunction in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 15:343–361, 2002

Dollery CM, McEwan JR, Henney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863–868, 1995

Maxwell PR, Timms PM, Chandran S, and Gordon D: Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabet Med 18:777–780, 2001